Jacqueline Katz

Q: What Schools Are Affiliated With Jacqueline Katz

Jacqueline Katz is affiliated with the following schools: University of Florida, University of Melbourne, Auburn University, Icahn School of Medicine at Mount Sinai, Cornell University, Texas A&M University, Kyoto University, Colorado State University

Jacqueline Katz's AcademicInfluence.com Rankings

Jacqueline Katz

Biology

#3966

World Rank

#5988

Historical Rank

Microbiology

#365

World Rank

#417

Historical Rank

Neuroscience

#1636

World Rank

#1687

Historical Rank

biology Degrees

Download Badge

Biology

Jacqueline Katz's Degrees

Masters Microbiology University of Melbourne

Why Is Jacqueline Katz Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jacqueline Marion Katz is an Australian-American microbiologist serving as the deputy director of the influenza division at the National Center for Immunization and Respiratory Diseases. Education Katz earned her Bachelor of Science degree in Microbiology and Biochemistry and her Ph.D. in Microbiology from the University of Melbourne. Her 1985 dissertation was titled, The T cell response to influenza virus in the mouse. She completed postdoctoral training in influenza virology.

(See a Problem?)

Jacqueline Katz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans (2009) (2458)
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. (1998) (1404)
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. (2009) (1301)
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. (2015) (1237)
Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus (2005) (1203)
Community-acquired pneumonia requiring hospitalization among U.S. children. (2015) (897)
Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays (1999) (831)
Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice (2009) (665)
H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice (2008) (637)
Transmission of Equine Influenza Virus to Dogs (2005) (624)
Cutting Edge: Impaired Toll-Like Receptor Expression and Function in Aging (2002) (597)
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission (2007) (552)
Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice (2005) (532)
Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals (2005) (482)
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. (2009) (442)
A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans (1999) (412)
Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice (2006) (408)
Innate immunity in aging: impact on macrophage function (2004) (398)
Human Illness from Avian Influenza H7N3, British Columbia (2004) (395)
Evolution of H5N1 Avian Influenza Viruses in Asia (2005) (383)
Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets (2002) (366)
Three Indonesian clusters of H5N1 virus infection in 2005. (2006) (347)
Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model (2006) (340)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. (2001) (338)
The ferret as a model organism to study influenza A virus infection (2011) (310)
Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice (2013) (308)
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. (2002) (308)
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. (1999) (298)
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. (2005) (296)
NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. (2007) (289)
Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization (2006) (276)
Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans (2000) (274)
Influenza: Propagation, Quantification, and Storage (2006) (273)
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. (1992) (265)
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. (2003) (264)
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. (1999) (261)
Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection (2001) (260)
Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. (2016) (254)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine (2009) (253)
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. (2000) (248)
Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001 (2005) (236)
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts (1992) (234)
Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from South Korea (2005) (234)
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. (2015) (225)
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air (2009) (211)
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation (2011) (204)
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility (2008) (199)
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. (1995) (198)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice (2006) (198)
Past, Present, and Possible Future Human Infection with Influenza Virus A Subtype H7 (2009) (194)
Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine (2018) (193)
Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus (1990) (191)
Confronting the avian influenza threat: vaccine development for a potential pandemic (2004) (189)
Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response (2008) (189)
The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses (2007) (182)
Influenza A Virus (H3N8) in Dogs with Respiratory Disease, Florida (2008) (179)
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. (2002) (174)
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus (2008) (166)
Host cell-mediated variation in H3N2 influenza viruses. (1987) (165)
Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells (2007) (162)
Modified M2 proteins produce heterotypic immunity against influenza A virus. (1999) (150)
Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. (1989) (149)
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines (2010) (143)
Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge (2009) (139)
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. (2006) (139)
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. (2001) (138)
Reproducibility of Serologic Assays for Influenza Virus A (H5N1) (2009) (137)
Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis (2010) (134)
Pathogenesis of Avian Influenza (H7) Virus Infection in Mice and Ferrets: Enhanced Virulence of Eurasian H7N7 Viruses Isolated from Humans (2007) (134)
Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. (2007) (132)
Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice (2010) (128)
Influenza Activity — United States, 2014–15 Season and Composition of the 2015–16 Influenza Vaccine (2015) (128)
DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. (2007) (125)
Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection (2010) (125)
Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. (2007) (124)
Avian influenza viruses infecting humans (2000) (121)
Immunological assessment of influenza vaccines and immune correlates of protection (2013) (118)
Reassortment between Avian H5N1 and Human H3N2 Influenza Viruses in Ferrets: a Public Health Risk Assessment (2009) (116)
Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957 (2010) (114)
Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice (2000) (111)
Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations (2011) (108)
Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. (2013) (107)
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. (2006) (106)
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. (2016) (106)
Influenza virus aerosol exposure and analytical system for ferrets (2011) (106)
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. (2011) (103)
Human Illness from Avian Influenza H7N3 (2004) (103)
Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. (2013) (103)
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein (2009) (102)
Influenza virus titration, antigenic characterization, and serological methods for antibody detection. (2012) (101)
The development of vaccine viruses against pandemic A(H1N1) influenza. (2011) (101)
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. (2008) (100)
Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice (2009) (100)
Pathogenesis of 1918 Pandemic and H5N1 Influenza Virus Infections in a Guinea Pig Model: Antiviral Potential of Exogenous Alpha Interferon To Reduce Virus Shedding (2009) (100)
Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999 (2002) (99)
Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. (2010) (99)
Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. (2009) (98)
Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication (2010) (97)
Human Pulmonary Microvascular Endothelial Cells Support Productive Replication of Highly Pathogenic Avian Influenza Viruses: Possible Involvement in the Pathogenesis of Human H5N1 Virus Infection (2011) (97)
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. (2001) (96)
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. (1997) (96)
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. (2007) (91)
Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. (2009) (91)
Low Pathogenic Avian Influenza A (H7N2) Virus Infection in Immunocompromised Adult, New York, USA, 2003 (2012) (90)
17 – Inactivated influenza vaccines (2013) (90)
N-Linked Glycosylation of the Hemagglutinin Protein Influences Virulence and Antigenicity of the 1918 Pandemic and Seasonal H1N1 Influenza A Viruses (2013) (89)
Generation, Characterization and Epitope Mapping of Two Neutralizing and Protective Human Recombinant Antibodies against Influenza A H5N1 Viruses (2009) (88)
Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. (2004) (87)
Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017 (2017) (85)
Application of Directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens (1992) (84)
Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. (2009) (82)
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. (2016) (82)
Effect of D222G Mutation in the Hemagglutinin Protein on Receptor Binding, Pathogenesis and Transmissibility of the 2009 Pandemic H1N1 Influenza Virus (2011) (81)
Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin (2013) (81)
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. (2000) (79)
Cytokine and Chemokine Profiles in Lung Tissues from Fatal Cases of 2009 Pandemic Influenza A (H1N1) (2013) (77)
Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine (2017) (77)
Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation (2011) (76)
Transmission and Pathogenesis of Swine-Origin 2009 A ( H 1 N 1 ) Influenza Viruses in Ferrets and Mice Citation (2010) (76)
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness (2018) (76)
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2013) (76)
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. (2014) (75)
Tropism and Infectivity of Influenza Virus, Including Highly Pathogenic Avian H5N1 Virus, in Ferret Tracheal Differentiated Primary Epithelial Cell Cultures (2012) (74)
Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice. (2013) (74)
Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. (1993) (74)
Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001 (2012) (72)
Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. (2005) (72)
Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. (2012) (72)
Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons (2019) (71)
Influenza A virus transmission: contributing factors and clinical implications (2010) (70)
Local innate immune responses and influenza virus transmission and virulence in ferrets. (2012) (70)
Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic — China, October 1, 2016–August 7, 2017 (2017) (70)
Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice (2010) (69)
Ocular Infection of Mice with Influenza A (H7) Viruses: a Site of Primary Replication and Spread to the Respiratory Tract (2009) (68)
Pathogenesis, Transmissibility, and Ocular Tropism of a Highly Pathogenic Avian Influenza A (H7N3) Virus Associated with Human Conjunctivitis (2013) (68)
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine. (2014) (68)
Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. (1992) (66)
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. (2008) (66)
Influenza Virus Respiratory Infection and Transmission Following Ocular Inoculation in Ferrets (2012) (66)
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. (2003) (66)
Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. (2003) (65)
Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual. (1988) (65)
Increased MDSC Accumulation and Th2 Biased Response to Influenza A Virus Infection in the Absence of TLR7 in Mice (2011) (65)
Update: Influenza Activity — United States, October 1, 2017–February 3, 2018 (2017) (63)
Pathogenesis and Transmission of Triple-Reassortant Swine H1N1 Influenza Viruses Isolated before the 2009 H1N1 Pandemic (2010) (62)
Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine (2012) (62)
Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic (2012) (61)
Immunity to influenza (2004) (60)
Pathogenesis of and immunity to avian influenza A H5 viruses. (2000) (60)
Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination (2001) (60)
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. (2011) (58)
Selection of antigenically advanced variants of seasonal influenza viruses (2016) (57)
Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2011) (56)
TLR7 Recognition Is Dispensable for Influenza Virus A Infection but Important for the Induction of Hemagglutinin-Specific Antibodies in Response to the 2009 Pandemic Split Vaccine in Mice (2012) (56)
Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. (1989) (56)
Rapid Differentiation of Monocytes into Type I IFN-Producing Myeloid Dendritic Cells as an Antiviral Strategy against Influenza Virus Infection (2012) (55)
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. (2006) (54)
Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting (2012) (53)
Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014. (2015) (53)
Influenza vaccines generated by reverse genetics. (2004) (53)
Transmission of 2009 Pandemic Influenza A (H1N1) Virus among Healthcare Personnel—Southern California, 2009 (2011) (52)
Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets (2015) (52)
The 2009 Pandemic H1N1 and Triple-Reassortant Swine H1N1 Influenza Viruses Replicate Efficiently but Elicit an Attenuated Inflammatory Response in Polarized Human Bronchial Epithelial Cells (2010) (51)
A(H7N9) Virus Results in Early Induction of Proinflammatory Cytokine Responses in both Human Lung Epithelial and Endothelial Cells and Shows Increased Human Adaptation Compared with Avian H5N1 Virus (2015) (50)
Influenza: Propagation, Quantification, and Storage (2013) (50)
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement (2016) (50)
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. (2012) (49)
Impact of Prior Seasonal H3N2 Influenza Vaccination or Infection on Protection and Transmission of Emerging Variants of Influenza A(H3N2)v Virus in Ferrets (2013) (48)
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. (2002) (48)
NLRC5 interacts with RIG‐I to induce a robust antiviral response against influenza virus infection (2015) (47)
The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I (2012) (47)
Comparison of the Levels of Infectious Virus in Respirable Aerosols Exhaled by Ferrets Infected with Influenza Viruses Exhibiting Diverse Transmissibility Phenotypes (2013) (46)
Novel influenza A viruses and pandemic threats (2017) (45)
Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans. (2014) (43)
Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins (2016) (43)
Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. (1994) (43)
New Pre‐pandemic Influenza Vaccines: An Egg‐ and Adjuvant‐independent Human Adenoviral Vector Strategy Induces Long‐lasting Protective Immune Responses in Mice (2007) (42)
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE (2015) (42)
Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein (1994) (42)
The Impact of Avian Influenza Viruses on Public Health (2003) (42)
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. (2011) (41)
Update: Influenza Activity - United States. (2015) (40)
Needle-Free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection against Lethal Challenge in Mice (2007) (40)
Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication (2014) (40)
Extent of γδ T cell involvement in the pneumonia caused by sendai virus (1992) (38)
The public health impact of avian influenza viruses. (2009) (38)
Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness (2013) (38)
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018 (2019) (38)
Transmission Studies Resume for Avian Flu (2013) (37)
Update: Influenza Activity — United States, September 28, 2014–February 21, 2015 (2015) (37)
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection among Workers at Live Bird Markets, Bangladesh, 2009–2010 (2015) (37)
Live Animal Markets in Minnesota: A Potential Source for Emergence of Novel Influenza A Viruses and Interspecies Transmission. (2015) (37)
Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011. (2011) (36)
Update: Influenza Activity — United States, September 30, 2018–February 2, 2019 (2019) (36)
Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets. (2011) (36)
Update: Influenza Activity — United States and Worldwide, May 21–September 23, 2017 (2015) (35)
A Distal Regulatory Region Is Required for Constitutive and IFN-β-Induced Expression of Murine TLR9 Gene (2005) (35)
Seasonal Trivalent Inactivated Influenza Vaccine Does Not Protect against Newly Emerging Variants of Influenza A (H3N2v) Virus in Ferrets (2012) (34)
Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. (2011) (34)
Influenza A(H1N1)pdm09 during air travel. (2013) (34)
Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010. (2010) (34)
Influenza Virus Infectivity and Virulence following Ocular-Only Aerosol Inoculation of Ferrets (2014) (33)
Systems-based candidate genes for human response to influenza infection☆ (2009) (33)
Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses (2015) (31)
Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004 (2009) (31)
Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines (2019) (31)
Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. (2011) (31)
Neurological Manifestations of Avian Influenza Viruses in Mammals (2003) (31)
IgM, IgG, and IgA Antibody Responses to Influenza A(H1N1)pdm09 Hemagglutinin in Infected Persons during the First Wave of the 2009 Pandemic in the United States (2014) (30)
Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections (2010) (30)
Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients (2014) (30)
Influenza A Virus Neuraminidase Protein Enhances Cell Survival through Interaction with Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) Protein* (2012) (30)
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (2010) (29)
Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice (2015) (29)
A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice. (2009) (29)
Ocular Tropism of Influenza A Viruses: Identification of H7 Subtype-Specific Host Responses in Human Respiratory and Ocular Cells (2011) (29)
Pathogenicity and antigenicity of a new influenza a (H5N1) virus isolated from duck meat (2003) (27)
Seroprevalence of Antibodies against Highly Pathogenic Avian Influenza A (H5N1) Virus among Poultry Workers in Bangladesh, 2009 (2013) (26)
Influenza Vaccination Accelerates Recovery of Ferrets from Lymphopenia (2014) (26)
Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice. (2013) (25)
Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly (1997) (25)
Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus Infection in Ferrets (2012) (25)
Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins (2014) (25)
Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets. (2015) (25)
Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production (2009) (24)
Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity. (2016) (24)
Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011. (2013) (23)
Infectivity Studies of Influenza Virus Hemagglutinin Receptor Binding Site Mutants in Mice (2008) (23)
A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008. (2011) (23)
Serological surveys for 2009 pandemic influenza A H1N1 (2010) (23)
Past , Present , and Possible Future Human Infection with Influenza Virus A Subtype H 7 (2010) (23)
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice. (2012) (22)
Considerations regarding appropriate sample size for conducting ferret transmission experiments. (2013) (22)
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children (2018) (22)
Prevalence of 2009 Pandemic Influenza A (H1N1) Virus Antibodies, Tampa Bay Florida — November–December, 2009 (2011) (21)
Diagnostic performance of the canine Influenza A Virus subtype H3N8 hemagglutination inhibition assay (2012) (21)
Update: Influenza Activity--United States, October 4, 2015-February 6, 2016. (2016) (21)
A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice. (2000) (21)
Avian Influenza A (H5N1) Virus Antibodies in Poultry Cullers, South Korea, 2003–2004 (2012) (20)
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010 (2011) (20)
Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness (2014) (20)
Mechanisms of Pathogenicity of Influenza A (H5N1) Viruses in Mice (2003) (19)
Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains. (1985) (19)
Update: Influenza Activity — United States, September 29, 2013–February 8, 2014 (2014) (19)
NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice (2016) (18)
Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time. (2013) (18)
Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects. (2001) (18)
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh (2018) (18)
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016. (2018) (17)
Pandemic H1N1 2009 and Drug Resistant Influenza Viruses are Potently Inhibited by DAS181, a Sialidase Fusion Protein (2009) (17)
Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses. (2015) (17)
Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults (2018) (17)
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. (2021) (17)
Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents (2014) (17)
Update: Influenza Activity — United States, October 1–November 25, 2017 (2017) (17)
Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013. (2013) (17)
Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets. (2015) (16)
In vitro antibody response to influenza virus. II. Specificity of helper T cell recognizing hemagglutinin. (1981) (16)
Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004. (2011) (16)
Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians—southwestern United States, May 1–July 21, 2009 (2013) (15)
Assessing the impact of public health interventions on the transmission of pandemic H1N1 influenza a virus aboard a Peruvian navy ship (2014) (15)
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost (2019) (15)
A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets. (2016) (15)
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets (2019) (15)
Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets. (2017) (14)
Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans (2017) (14)
Update: Influenza Activity — United States and Worldwide, May 20–October 13, 2018 (2018) (14)
Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus. (2014) (14)
Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus. (2015) (14)
Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains. (2016) (14)
Update: Influenza Activity — United States, October 2, 2016–February 4, 2017 (2017) (14)
Pathogenicity testing of influenza candidate vaccine viruses in the ferret model. (2017) (13)
An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice. (2016) (13)
No Evidence of Avian Influenza A H5N1 among Returning US Travelers (2007) (13)
DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice (2002) (13)
A highly immunogenic vaccine against A/H7N9 influenza virus. (2016) (13)
Innovations in modeling influenza virus infections in the laboratory (2012) (13)
Kinetics of viral replication and induction of host responses in ferrets differs between ocular and intranasal routes of inoculation. (2013) (13)
Serologic Evidence of Influenza A(H1N1)pdm09 Virus Infection in Northern Sea Otters (2014) (12)
Effect of D 222 G Mutation in the Hemagglutinin Protein on Receptor Binding , Pathogenesis and Transmissibility of the 2009 Pandemic H 1 N 1 Influenza Virus (2011) (12)
Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005. (2006) (11)
Oseltamivir Inhibits H7 Influenza Virus Replication in Mice Inoculated by the Ocular Route (2011) (11)
Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses. (2011) (10)
Human infection with avian influenza A(H7N2) virus—Virginia, 2002 (2018) (10)
Immune responses to infection with H5N1 influenza virus. (2013) (10)
Infection of lung epithelial cells with pandemic 2009 A(H1N1) influenza viruses reveals isolate-specific differences in infectivity and host cellular responses. (2011) (10)
Population biology, evolution, and immunology of vaccination and vaccination programs. (1998) (10)
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells (2007) (10)
Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses. (2017) (9)
Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses. (2006) (9)
AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes. (2015) (9)
The 2009 Pandemic H 1 N 1 and Triple-Reassortant Swine H 1 N 1 Influenza Viruses Replicate Efficiently but Elicit an Attenuated Inflammatory Response in Polarized Human Bronchial Epithelial Cells (2010) (8)
Seropositivity for Influenza A(H1N1)pdm09 Virus among Frontline Health Care Personnel (2013) (8)
Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015. (2015) (8)
Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand. (2016) (8)
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice (2017) (8)
Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice. (2013) (8)
Improved specificity and reduced subtype cross-reactivity for antibody detection by ELISA using globular head domain recombinant hemagglutinin. (2014) (7)
Novel multiplex assay platforms to detect influenza A hemagglutinin subtype‐specific antibody responses for high‐throughput and in‐field applications (2017) (7)
Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin. (1987) (7)
New England Medical Journal (2007) (7)
Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin. (2014) (7)
International Laboratory Comparison of Influenza Microneutralization Assays for A ( H 1 N 1 ) pdm 09 , A ( H 3 N 2 ) , and A ( H 5 N 1 ) Influenza Viruses by CONSISE (2015) (7)
Pathogenesis of and Immunity to a New Influenza A (H5N1) Virus Isolated from Duck Meat (2003) (6)
Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription. (2020) (6)
Murine helper T lymphocyte response to influenza virus: recognition of haemagglutinin by subtype-specific and cross-reactive T cell clones. (1985) (6)
Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines (2004) (6)
A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants (2016) (6)
Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans. (2016) (6)
Update: Influenza Activity - United States and Worldwide, May 22-September 10, 2016. (2016) (6)
Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009–2011 (2018) (6)
Extent of gamma delta T cell involvement in the pneumonia caused by Sendai virus. (1992) (5)
Influenza Activity — United States, September 30–December 1, 2018 (2018) (5)
THE SPECIFICITY OF T CELLS FOR INFLUENZA VIRUS HEMAGGLUTININ (1981) (5)
Update: Influenza Activity - United States, October 2-December 17, 2016. (2016) (4)
Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines. (2014) (4)
Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants (2017) (4)
Update: Influenza Activity — United States, September 29–December 7, 2013 (2013) (4)
The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: a serologic investigation demonstrating early transmission (2012) (4)
A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic (2016) (4)
Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh (2017) (3)
Antigenic characteristics of recent avian influenza A H5N1 viruses isolated from humans (2004) (3)
Population-Based Surveillance for Zoonotic Influenza a Infections Among Agricultural Workers (2006) (3)
Protecting adults from influenza: tis the season to learn from the pandemic. (2012) (3)
Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin (2018) (3)
Expression and Function in Aging Cutting Edge: Impaired Toll-Like Receptor (2002) (3)
[Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. (1998) (3)
Seroincidence of Influenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 Influenza Pandemic, Bangkok, Thailand (2014) (2)
WHO-NIH meeting on host cell selection of influenza virus variants. 13-14 November 1991, National Institute for Biological Standards and Control, Hertfordshire, UK. (1992) (2)
[Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. (2000) (2)
[In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. (2000) (2)
Pandemic Virus Characterization of the Reconstructed 1918 Spanish Influenza (2012) (2)
A Newly Emerged Swine-Origin Influenza A(H3N2) Variant Dampens Host Antiviral Immunity but Induces Potent Inflammasome Activation. (2015) (2)
Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2013 (2013) (2)
Mucosal vaccination protects mice against influenza A heterosubtypic challenge (2001) (1)
DAS181 and H5N1 Virus Infection. Authors' reply (2009) (1)
Options for the Control of Influenza VI Conference summary (2007) (1)
Reply to Zhang (2009) (1)
Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection. (2011) (1)
Replication and Mortality in Mice and Neutrophils in Limiting Virus Functional Roles of Alveolar Macrophages Genes from the 1918 Pandemic Virus : Pathogenicity of Influenza Viruses with (2005) (1)
Increased Dietary Salt Intake Does Not Influence Influenza A Virus-Induced Disease Severity in Mice. (2015) (1)
Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States (2017) (1)
Current methods for assessing T cell responses to influenza. (2003) (1)
Role of human IgM memory B cells in influenza vaccine response (P4401) (2013) (1)
Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to In fl uenza Infection in Mice (2013) (1)
Adverse role of influenza A virus-induced Nox1 in neutralizing antibody responses and survival against lethal viral challenge in mice. (P1407) (2013) (1)
drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (2010) (1)
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness (2018) (1)
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost (2019) (1)
PSS282 - Nox1 as a Therapeutic Target to Improve Survival in Influenza a Infection (2013) (0)
Evolution oftheH3Influenza VirusHemagglutinin from HumanandNonhumanHosts (1992) (0)
335 Demographics of Acute Care Health Care Workers Who Seroconverted After Receiving the 2009 H1N1 Monovalent Vaccine (2011) (0)
Influenza pandemic vaccines: the imminent challenges from a technical and regulatory perspective (2004) (0)
, Populations with 2009 Pandemic H 1 N 1 Virus in U . S . Assays for Detection of Human Infection Sensitivity and Specificity of Serologic (2011) (0)
Vaccines against avian influenza A H9N2 viruses (2001) (0)
Role of CD8+ αβ T Cells in Respiratory Infections Caused by Sendai Virus and Influenza Virus (1993) (0)
Alexander (Sasha) I. Klimov, PhD, ScD (1943–2013) (2013) (0)
CME ACTIVITY: Past, Present, and Possible Future Human Infection with Influenza Virus A Subtype H7 (2009) (0)
INFLUENZA A VIRUS NEURAMINIDASE PROTEIN ENHANCES CELL SURVIVAL THROUGH INTERACTION WITH CEACAM6 (2012) (0)
Haemagglutination inhibition (HI) and virus neutralization (VN) titers in hen sera and egg yolks. (2013) (0)
An international laboratory comparison of influenza microneutralisation assay 2 (2015) (0)
608. Dose Escalation of Recombinant Adenovirus-Based Influenza Virus Vaccine Encoding the Full Length Hemagglutinin (HA) of the A/Vietnam/1203/2004 (H5N1) To Immunize Naïve and Ad-Immune Mice (2006) (0)
A cationic lipid-DNA complex adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of influenza pre-pandemic H5N1 vaccine in ferrets (VAC2P.931) (2014) (0)
Adjuvanting influenza vaccines for enhanced immunity to seasonal or pandemic influenza virus. (75.9) (2012) (0)
Age-related prevalence of serum hemagglutination-inhibition antibodies cross-reactive to 2012 and 2013 newly emerging swine-origin influenza A(H3N2) variant viruses (VIR5P.1134) (2015) (0)
Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity (2022) (0)
A cationic lipid/DNA complexes (JVRS-100) combined with influenza A H5N1 vaccine induce long-term antibody responses and protection against H5N1 virus in BALB/c mice (155.31) (2011) (0)
Generation of candidate H5N1 and H9N2 influenza vaccines for pandemic preparedness (2001) (0)
Infection an Antiviral Strategy against Influenza Virus I IFN-Producing Myeloid Dendritic Cells as Rapid Differentiation of Monocytes into Type (2012) (0)
recombinant adenovirus vector, recombinant adenovirus, immunogenic composition and method for the production of said immunogenic composition (2006) (0)
Early Control of H5N1 Inﬂuenza Virus Replication by the Type I Interferon Response in Mice (cid:1) (2009) (0)
Antigenic and molecular variation in subpopulations of influenza viruses isolated from an infected individual in different host cells (1988) (0)
404 Accuracy of Body Weight Estimates in Acute Emergency Department Stroke Patients (2011) (0)
DAS 181 and H 5 N 1 Virus Infection (0)
Virulence of highly pathogenic avian influenza H5N1 viruses in mammals (2009) (0)
Pathogenesis and Transmission of Triple-Reassortant Swine H1N1 Inﬂuenza Viruses Isolated before the 2009 H1N1 Pandemic (cid:1) (2011) (0)
A novel quinazolin-derived reactive oxygen species-inhibitor suppresses influenza A virus-induced inflammatory mediators and leads to enhanced survival in mice (P4214) (2013) (0)
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets (2019) (0)
Materials and methods for the control of canine respiratory disease (2006) (0)
66. A Protective Vaccine for the Rapid Response to Pandemic AVian Influenza (2005) (0)
Title Novel pandemic influenza A ( H 1 N 1 ) viruses are potently inhibitedby DAS 181 , a sialidase fusion protein (2009) (0)
Influenza Virus Pathogenesis in Mammalian Species (2004) (0)
Increased Myeloid Derived Suppressor Cell recruitment and skewed TH2 response during influenza A virus infection in the absence of TLR7. (49.21) (2011) (0)
Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection. (67.5) (2011) (0)
[Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. (1998) (0)
Systemic and cellular immunity. (2003) (0)
Ocular Infection of Mice with Inﬂuenza A (H7) Viruses: a Site of Primary Replication and Spread to the Respiratory Tract (cid:1) (2009) (0)
Seroincidence of In ﬂ uenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 In Bangkok, Thailand (2014) (0)
Induced by Infection and Vaccination Immunity to Influenza A H 9 N 2 Viruses (2001) (0)
Production of interleukin-2 in vitro and in vivo in elderly subjects vaccinated with live and inactivated influenza vaccines and their combination. (2000) (0)
Pathogenesis of Avian Inﬂuenza (H7) Virus Infection in Mice and Ferrets: Enhanced Virulence of Eurasian H7N7 Viruses Isolated from Humans (cid:1) (2007) (0)

This paper list is powered by the following services:

Other Resources About Jacqueline Katz

en.wikipedia.org

What Schools Are Affiliated With Jacqueline Katz?

Jacqueline Katz is affiliated with the following schools:

Jacqueline Katz's Academic­Influence.com Rankings

Jacqueline Katz's Degrees

Why Is Jacqueline Katz Influential?

Jacqueline Katz's Published Works

Published Works

Other Resources About Jacqueline Katz

What Schools Are Affiliated With Jacqueline Katz?

Jacqueline Katz's AcademicInfluence.com Rankings